Skip to content

Clinical trials

Withdrawn Phase 2 Pancreatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 2 Status: Withdrawn Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20081
20091
20101
20121
20151
20162
20175
20182
20192
20201
20223
20231
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Case Comprehensive Cancer Center1
Centre Francois Baclesse, Luxembourg1
Cornerstone Pharmaceuticals1
Fuda Cancer Hospital, Guangzhou1
Genfleet Therapeutics (Shanghai) Inc.1
Georgetown University1
HonorHealth Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms34
Neoplasms5
Adenocarcinoma2
Duodenal Neoplasms2
Anorexia1
Biliary Tract Neoplasms1
Bites and Stings1
Cachexia1
Carcinoma, Pancreatic Ductal1
Cholangiocarcinoma1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.